Skip to main content

Animations

MJFF Publications

2531 - 2540 of 8816 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2024
  • 2023
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad331
    Citation Count: 16
  • Summary Details
    OPEN
    Title: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad247
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad246
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00738-4
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Atypical antipsychotic use and mortality risk in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2024.1349030
    Citation Count: 7
  • Summary Details
    OPEN
    Title: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00723-x
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Orthogonal analysis of mitochondrial function in Parkinson’s disease patients
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06617-6
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.